4//SEC Filing
Sniecinski Megan 4
Accession 0001127602-20-031803
CIK 0000882796other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:45 PM ET
Size
5.1 KB
Accession
0001127602-20-031803
Insider Transaction Report
Form 4
Sniecinski Megan
Chief Business Officer
Transactions
- Award
Emp. Stock Option (Right to Buy)
2020-12-15+225,000→ 225,000 totalExercise: $8.31From: 2021-12-15Exp: 2030-12-15→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001781480
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:45 PM ET
- Size
- 5.1 KB